Negative Expression of Thymidylate Synthase (TYMS), O-6-Methylguanine-DNA Methyltransferase (MGMT), and BCL-2 as Theranostic Biomarkers in Triple Negative Breast Cancer Patients
Keyword(s): Identification of biomarkers in triple negative breast cancer, Triple Negative Breast Cancer (TNBC) Theranostic Biomarkers TYMS (Thymidylate Synthase) MGMT (O6-Methylguanine-DNA Methyltransferase) BCL-2 Negative Expression Personalized Medicine Predictive Biomarkers Targeted Therapy Drug Resistance
Year: 2025
Interested in this project?
If you would like to learn more about this project or explore a potential collaboration with the research team,
please contact us (The project title will be quoted automatically). We will forward your enquiry to the project lead to explore potential
opportunities for collaboration.
